Free Daily Analysis

Stock Trend Analysis Report

Prepared for you on Tuesday, March 28, 2023.

Atea Pharmaceuticals, Inc. - common stock (NASDAQ:AVIR)

Strong Downtrend (-100) - AVIR is in a strong downtrend that is likely to continue. With short-term, intermediate, and long-term bearish momentum, AVIR continues to fall. Traders should use caution and set stops.

Is it time to buy, sell, or avoid AVIR?

MarketClub looks at technical strength and momentum to determine if the timing is right for AVIR.

Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.

NASDAQ_AVIR
Open High Low AVIR Price Change
3.140 3.180 3.060 3.135 -0.025
Entry Signal

MarketClub’s Trade Triangles for AVIR

long term down The long-term trend has been DOWN since Sep 19th, 2022 at 6.080

intermediate term down The intermediate-term trend has been DOWN since Jan 24th, 2023 at 4.610

short term down The short-term trend has been DOWN since Mar 20th, 2023 at 3.367

Smart Scan Analysis for AVIR

Based on our trend formula, AVIR is rated as a -100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

-100
Smart Scan Analysis for AVIR
Strong Downtrend Sideways Strong Uptrend
Open High Low Price Change
3.140 3.180 3.060 3.135 -0.025
Prev. Close Volume Bid Ask Time
3.160 100849 2023-03-28 11:27:52
52wk High9.7952wk High Date2022-08-09
52wk Low2.9452wk Low Date2023-03-24
Average Volume796,362Shares Outstanding83,288
Assets666,708,000MLiabilities26,136,000M
P/E Ratio10.1515
Get a free daily analysis and signals for Atea Pharmaceuticals, Inc. - common stock (AVIR) - Request Your Free Report.